与神经母细胞瘤相关的治疗相关的第二种恶性瘤:频率,类型和危险因素
Mohamed Fawzy1,2, Nihal Abdelfattah3, Menna Alaa4
1Department of Pediatric Oncology, Children's Cancer Hospital Egypt-57357, Cairo, Egypt.
Discover oncology
|May 21, 2025
概括
接受多模式治疗的神经母细胞瘤患者面临1%的二次恶性瘤 (SMN) 风险,主要是血液性. 高风险疗法和特定的化疗药物增加了这种风险.
科学领域:
- 儿科瘤学 儿科瘤学
- 癌症研究 癌症研究
- 血液学 血液学 血液学
背景情况:
- 神经母细胞瘤是一种常见的儿童癌症.
- 治疗方案旨在最大限度地提高治愈率,同时最大限度地减少长期副作用.
- 二次性恶性瘤 (SMN) 是长期癌症幸存者的一个问题.
研究的目的:
- 评估神经母细胞瘤患者与治疗相关的二次恶性瘤 (SMN) 的长期风险.
- 在这个队列中确定与SMN发展相关的因素.
主要方法:
- 在2007年7月至2022年12月期间接受治疗的神经母细胞瘤患者的回顾性研究.
- 对治疗方案的分析和SMN的开发.
主要成果:
- 1% (24/2290) 的患者患有SMN,主要是血液性 (21/24).
- 血液型 (平均3.7年) 的SMN发育时间比固体型 (平均7.6年) 短.
- 在受影响的患者中,高累积剂量的ifosfamide,cyclophosphamide和etoposide是常见的.
结论:
- 与固体SMN相比,神经母细胞瘤患者患血液性SMN的风险更高.
- 高风险的治疗方案和基化剂和多酶II抑制剂的累积剂量与SMN风险增加有关.
更多相关视频
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
1.2K
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
408
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
